B. Scatton

20.0k citations

290 papers · 16.5k indexed · 1 hit paper · h-index 73

Cellular and Molecular Neuroscience top 0.05%
- Neuroscience and Neuropharmacology Research 157
- Neurotransmitter Receptor Influence on Behavior 102
- Neuropeptides and Animal Physiology 19
Behavioral Neuroscience top 0.2%
Biological Psychiatry top 0.5%
Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 21
Cognitive Neuroscience top 0.5%
Molecular Biology
- Receptor Mechanisms and Signaling 73
- Ion channel regulation and function 18
- Pharmacological Receptor Mechanisms and Effects 16
Psychiatry and Mental health
- Epilepsy research and treatment 16

Co-authors: Jesús Bénavidès A Dubois Christopher Carter A. Serrano Dominique Fage L. Rouquier Toru Nishikawa Michel Le Moal
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Biological Psychiatry
Journals: Brain Research (55 papers)Journal of Pharmacology and Experimental Therapeutics (34 papers)European Journal of Pharmacology (30 papers)
Partner nations: France United States Sweden

In The Last Decade

B. Scatton

286 papers receiving 15.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by B. Scatton

Since Specialization

Citations

This map shows the geographic impact of B. Scatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Scatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Scatton more than expected).

Fields of papers citing papers by B. Scatton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Scatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Scatton. The network helps show where B. Scatton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Scatton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Scatton Line = papers co-authored together B. Scatton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus European Journal of Neuroscience ·Frédéric Bequet,L. Eaves,Robert Czeladko,Yohei Koseki,Mohamed Maftouh,C. Picard,B. Scatton,Gérard Le Fur	2007	47
2	SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal,Т.И. Мелентьева,和夫志位,Guy Germain,Charles Advenier,Emmanuel Naline,Marc Bardou,Andi Ridwan,Brigitte Pouzet,Danielle Raufaste,Corinne Garcia,Wanjia Lu,于占华,Marc Pascal,A. Barbier,B. Scatton,Jean‐Pierre Maffrand,Gérard Le Fur	2004	41
3	SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile Neuropsychopharmacology ·Y. Claustre,Saed Rahwanji,Philippe Brun,Christiane Gueudet,Tae-Min Kim,Richard Alonso,T. G. Whitet,André Oblin,E Szewczyk,Dominique Françon,Marie‐Françoise Suaud‐Chagny,R. Steinberg,Mireille Sevrin,Hans E. Schoemaker,Pascal George,Philippe Soubrié,B. Scatton	2003	41
4	Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders Proceedings of the National Academy of Sciences ·Guy Griebel,Jacques Simiand,Claudine Serradeil‐Le Gal,Jean Wagnon,Marc Pascal,B. Scatton,Jean‐Pierre Maffrand,Philippe Soubrié	2002	381
5	Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal,Jean Wagnon,Jacques Simiand,Guy Griebel,C Lacour,Gilles Guillon,Claude Barberis,Richard J. Pym,Philippe Soubrié,Dino Nisato,Marc Pascal,Rebecca M. Pruss,B. Scatton,Jean‐Pierre Maffrand,Gérard Le Fur	2002	180
6	The preclinical pharmacologic profile of tiapride European Psychiatry ·B. Scatton,Caroline Cohen,Ghislaine Perrault,A. Oblin,Y. Claustre,H. Schoemaker,D. J. Sanger,L. Rouquier,Roger D. Porsolt	2001	35
7	Pharmacological and molecular targets in the search for novel antipsychotics Behavioural Pharmacology ·B. Scatton,D. J. Sanger	2000	30
8	Amisulpride: from animal pharmacology to therapeutic action International Clinical Psychopharmacology ·B. Scatton,Y. Claustre,Annie Cudennec,A. Oblin,Ghislaine Perrault,D. J. Sanger,Hans E. Schoemaker	1997	100
9	Quantitative motor assessment in FALS mice Neuroreport ·Pascal Barnéoud,R.S. Desai,D. J. Sanger,B. Scatton,Paul Moser	1997	69
10	アミスルプリドの精神薬理学的プロフィール前シナプス性D 2 /D 3 ドーパミン受容体きっ抗薬活性と辺縁系選択性を有する向精神薬 Journal of Pharmacology and Experimental Therapeutics ·Ghislaine Perrault,Ronan Depoortère,Jan Muszyński,Xiran Du,B. Scatton	1997	2
11	Place de l'amisulpride dans la classe des neuroleptiques atypiques Ghislaine Perrault,Rik C. Schoemaker,B. Scatton	1996	2
12	Release of spermidine from the rat cortex following permanent middle cerebral artery occlusion Fundamental and Clinical Pharmacology ·Christopher Carter,H. Poignet,Susanna Carboni,Dominique Fage,C. Voltz,B. Scatton	1995	19
13	Dihydropyridine- and omega-conotoxin-resistant, neomycin-sensitive calcium channels mediate the depolarization-induced increase in internal calcium levels in cortical slices from immature rat brain. Journal of Pharmacology and Experimental Therapeutics ·Vidarthi Bahmaniya,B. Scatton,Jesús Bénavidès	1992	28
14	The psychopharmacology of GABA synapses: update 1989 PubMed ·Kenneth G. Lloyd,Philippe Pichat,B. Scatton,B. Živković,P. L. Morselli,G. Bartholini	1990	8
15	Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor European Journal of Pharmacology ·Christopher Carter,Iim Calcutta Raghabendra Chattopadhyay,B. Scatton	1989	117
16	The gabaergic hypothesis of depression Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Kenneth G. Lloyd,Branimir Ẑivković,B. Scatton,P. L. Morselli,Abbas A. Al-Duliami عباس الدليمي	1989	87
17	Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex Neuroscience ·F. Javoy‐Agid,B. Scatton,Merle Ruberg,Nur Afiqah Meor Ahmad,Pascale Cervera,Rita Raisman,J.M. Maloteaux,Heinz Beck,Yves Agid	1989	65
18	Platelet Monoamine Oxidase Activity and Plasma 3,4-Dihydroxy-phenylethylene Glycol Levels during the Menstrual Cycle Neuropsychobiology ·Marie‐France Poirier,Henri Lôo,史永强,Gérard Le Fur,B. Scatton	1985	25
19	Dopamine metabolism in the rat retina and brain after acute and repeated treatment with neuroleptics. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·B. Scatton,J. Dedek,J. Korf	1978	1
20	Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Sara Granero,Jean‐Pol Tassin,Gérard Blanc,L. Stinus,B. Scatton,J. Głowiński	1977	30

About B. Scatton

B. Scatton is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Biological Psychiatry, having authored 290 papers that have together received 16.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (157 papers), Neurotransmitter Receptor Influence on Behavior (102 papers), Receptor Mechanisms and Signaling (73 papers), Parkinson's Disease Mechanisms and Treatments (21 papers), Neuropeptides and Animal Physiology (19 papers), Ion channel regulation and function (18 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Epilepsy research and treatment (16 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (10.4k citations), Behavioral Neuroscience (1.3k citations) and Biological Psychiatry (604 citations). B. Scatton has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Jesús Bénavidès, A Dubois, Christopher Carter, A. Serrano, Dominique Fage, L. Rouquier, Toru Nishikawa, Michel Le Moal, T Dennis and Marc Savasta. Their work appears in journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology, Journal of Neurochemistry and Naunyn-Schmiedeberg s Archives of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact